US - Catalent To Be Acquired By Novo Holdings.

February 16, 2024 by Rohin Pujari

Skadden is representing contract drug manufacturer Catalent, Inc. in its $16.5 billion acquisition by Novo Holdings A/S.

Error: Contact form not found.

US – Catalent To Be Acquired By Novo Holdings.